A proposed cholinergic phenotype of Parkinson’s disease: candidate clinical, biofluid, and imaging markers
Objective Various non-motor symptom (NMS)-dominant clinical subtypes are recognised in Parkinson’s disease (PD), and a cognitive dysfunction-dominant “cholinergic subtype” has also been proposed. Cognitive impairment of varying degrees occurs in the prodromal phase of PD and is partly related to dysfunction of central...